These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 27984508)
1. Characterization of ADME gene variation in 21 populations by exome sequencing. Hovelson DH; Xue Z; Zawistowski M; Ehm MG; Harris EC; Stocker SL; Gross AS; Jang IJ; Ieiri I; Lee JE; Cardon LR; Chissoe SL; Abecasis G; Nelson MR Pharmacogenet Genomics; 2017 Mar; 27(3):89-100. PubMed ID: 27984508 [TBL] [Abstract][Full Text] [Related]
2. Imputation-based assessment of next generation rare exome variant arrays. Martin AR; Tse G; Bustamante CD; Kenny EE Pac Symp Biocomput; 2014; ():241-52. PubMed ID: 24297551 [TBL] [Abstract][Full Text] [Related]
3. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome. Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657 [TBL] [Abstract][Full Text] [Related]
4. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing. Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994 [TBL] [Abstract][Full Text] [Related]
5. Global inference of disease-causing single nucleotide variants from exome sequencing data. Wu M; Chen T; Jiang R BMC Bioinformatics; 2016 Dec; 17(Suppl 17):468. PubMed ID: 28155632 [TBL] [Abstract][Full Text] [Related]
6. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies. Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592 [TBL] [Abstract][Full Text] [Related]
7. Exome sequencing of only seven Qataris identifies potentially deleterious variants in the Qatari population. Rodriguez-Flores JL; Fuller J; Hackett NR; Salit J; Malek JA; Al-Dous E; Chouchane L; Zirie M; Jayoussi A; Mahmoud MA; Crystal RG; Mezey JG PLoS One; 2012; 7(11):e47614. PubMed ID: 23139751 [TBL] [Abstract][Full Text] [Related]
8. iCall: a genotype-calling algorithm for rare, low-frequency and common variants on the Illumina exome array. Zhou J; Tantoso E; Wong LP; Ong RT; Bei JX; Li Y; Liu J; Khor CC; Teo YY Bioinformatics; 2014 Jun; 30(12):1714-20. PubMed ID: 24567545 [TBL] [Abstract][Full Text] [Related]
9. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodríguez-Antona C Genet Med; 2018 Jun; 20(6):622-629. PubMed ID: 29261188 [TBL] [Abstract][Full Text] [Related]
10. Determining multiallelic complex copy number and sequence variation from high coverage exome sequencing data. Forni D; Martin D; Abujaber R; Sharp AJ; Sironi M; Hollox EJ BMC Genomics; 2015 Nov; 16():891. PubMed ID: 26526070 [TBL] [Abstract][Full Text] [Related]
15. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease. Blue GM; Kirk EP; Giannoulatou E; Dunwoodie SL; Ho JW; Hilton DC; White SM; Sholler GF; Harvey RP; Winlaw DS J Am Coll Cardiol; 2014 Dec; 64(23):2498-506. PubMed ID: 25500235 [TBL] [Abstract][Full Text] [Related]
16. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population. Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958 [TBL] [Abstract][Full Text] [Related]
17. Exome sequencing explained: a practical guide to its clinical application. Seaby EG; Pengelly RJ; Ennis S Brief Funct Genomics; 2016 Sep; 15(5):374-84. PubMed ID: 26654982 [TBL] [Abstract][Full Text] [Related]
18. Exome versus transcriptome sequencing in identifying coding region variants. Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815 [TBL] [Abstract][Full Text] [Related]
19. Exome sequencing followed by genotyping suggests SYPL2 as a susceptibility gene for morbid obesity. Jiao H; Arner P; Gerdhem P; Strawbridge RJ; Näslund E; Thorell A; Hamsten A; Kere J; Dahlman I Eur J Hum Genet; 2015 Sep; 23(9):1216-22. PubMed ID: 25406998 [TBL] [Abstract][Full Text] [Related]
20. Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes. Lotta LA; Wang M; Yu J; Martinelli I; Yu F; Passamonti SM; Consonni D; Pappalardo E; Menegatti M; Scherer SE; Lewis LL; Akbar H; Wu Y; Bainbridge MN; Muzny DM; Mannucci PM; Gibbs RA; Peyvandi F BMC Med Genomics; 2012 Feb; 5():7. PubMed ID: 22353194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]